These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 18004779)

  • 1. Solution structure and neutralizing antibody binding studies of domain III of the dengue-2 virus envelope protein.
    Huang KC; Lee MC; Wu CW; Huang KJ; Lei HY; Cheng JW
    Proteins; 2008 Feb; 70(3):1116-9. PubMed ID: 18004779
    [No Abstract]   [Full Text] [Related]  

  • 2. Differential expression of domain III neutralizing epitopes on the envelope proteins of West Nile virus strains.
    Li L; Barrett AD; Beasley DW
    Virology; 2005 Apr; 335(1):99-105. PubMed ID: 15823609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of an antigenic site that contains a dominant, type-specific neutralization determinant on the envelope protein domain III (ED3) of dengue 2 virus.
    Gromowski GD; Barrett AD
    Virology; 2007 Sep; 366(2):349-60. PubMed ID: 17719070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diversity and junction residues as hotspots of binding energy in an antibody neutralizing the dengue virus.
    Bedouelle H; Belkadi L; England P; Guijarro JI; Lisova O; Urvoas A; Delepierre M; Thullier P
    FEBS J; 2006 Jan; 273(1):34-46. PubMed ID: 16367746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive mapping of functional epitopes on dengue virus glycoprotein E DIII for binding to broadly neutralizing antibodies 4E11 and 4E5A by phage display.
    Frei JC; Kielian M; Lai JR
    Virology; 2015 Nov; 485():371-82. PubMed ID: 26339794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of dengue complex-reactive epitopes on dengue 3 virus envelope protein domain III.
    Matsui K; Gromowski GD; Li L; Schuh AJ; Lee JC; Barrett AD
    Virology; 2009 Feb; 384(1):16-20. PubMed ID: 19101005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations of an antibody binding energy hot spot on domain III of the dengue 2 envelope glycoprotein exploited for neutralization escape.
    Gromowski GD; Roehrig JT; Diamond MS; Lee JC; Pitcher TJ; Barrett AD
    Virology; 2010 Nov; 407(2):237-46. PubMed ID: 20832836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amino acid changes in the recombinant Dengue 3 Envelope domain III determine its antigenicity and immunogenicity in mice.
    Zulueta A; Martín J; Hermida L; Alvarez M; Valdés I; Prado I; Chinea G; Rosario D; Guillén G; Guzmán MG
    Virus Res; 2006 Oct; 121(1):65-73. PubMed ID: 16781791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Localization of a neutralizing epitope on the envelope protein of dengue virus type 2.
    Lin B; Parrish CR; Murray JM; Wright PJ
    Virology; 1994 Aug; 202(2):885-90. PubMed ID: 7518164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure of the envelope protein domain III of Omsk hemorrhagic fever virus.
    Volk DE; Chavez L; Beasley DW; Barrett AD; Holbrook MR; Gorenstein DG
    Virology; 2006 Jul; 351(1):188-95. PubMed ID: 16647096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacterially expressed and refolded envelope protein (domain III) of dengue virus type-4 binds heparan sulfate.
    Pattnaik P; Babu JP; Verma SK; Tak V; Rao PV
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Feb; 846(1-2):184-94. PubMed ID: 17011249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Recombinant envelope glycoprotein domain III of dengue virus inhibit virus infection].
    Lu P; Wei Y; Cao SC; Li JD; Liu QZ; Zhang QF; Li C; Miao F; Zhang S; Hang XT; Liang MF; Li DX
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Jun; 22(3):177-9. PubMed ID: 19031695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Production of dengue 2 envelope domain III in plant using TMV-based vector system.
    Saejung W; Fujiyama K; Takasaki T; Ito M; Hori K; Malasit P; Watanabe Y; Kurane I; Seki T
    Vaccine; 2007 Sep; 25(36):6646-54. PubMed ID: 17659815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dengue virus type 2 envelope protein displayed as recombinant phage attachment protein reveals potential cell binding sites.
    Abd-Jamil J; Cheah CY; AbuBakar S
    Protein Eng Des Sel; 2008 Oct; 21(10):605-11. PubMed ID: 18669522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional epitopes on porcine endogenous retrovirus envelope protein interacting with neutralizing antibody combining sites.
    Chiang CY; Pan YR; Chou LF; Fang CY; Wang SR; Yang CY; Chang HY
    Virology; 2007 May; 361(2):364-71. PubMed ID: 17222436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High resolution crystal structure of dengue-3 envelope protein domain III suggests possible molecular mechanisms for serospecific antibody recognition.
    Elahi M; Islam MM; Noguchi K; Yohda M; Kuroda Y
    Proteins; 2013 Jun; 81(6):1090-5. PubMed ID: 23239402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a heparin binding peptide from the Japanese encephalitis virus envelope protein.
    Chen HL; Her SY; Huang KC; Cheng HT; Wu CW; Wu SC; Cheng JW
    Biopolymers; 2010; 94(3):331-8. PubMed ID: 20069543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SIV neutralization epitopes.
    Javaherian K; Langlois AJ; LaRosa GJ
    Chem Immunol; 1993; 56():78-90. PubMed ID: 7680868
    [No Abstract]   [Full Text] [Related]  

  • 19. High-level expression and one-step purification of recombinant dengue virus type 2 envelope domain III protein in Escherichia coli.
    Jaiswal S; Khanna N; Swaminathan S
    Protein Expr Purif; 2004 Jan; 33(1):80-91. PubMed ID: 14680965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody recognition of HIV and dengue glycoproteins.
    Krauss IJ
    Glycobiology; 2016 Aug; 26(8):813-9. PubMed ID: 26941393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.